FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Denton David M
2. Issuer Name and Ticker or Trading Symbol

CVS HEALTH Corp [ CVS ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
EVP and CFO
(Last)          (First)          (Middle)

ONE CVS DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)

2/20/2018
(Street)

WOONSOCKET, RI 02895-
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock (restricted)   2/20/2018     J    38836   (1) D $0   114041   D    
Common Stock   2/20/2018     J    18057   (2) D $0   18400.99   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option   $74.29   2/20/2018     J         30325   (3)   4/1/2015   (4) 4/1/2021   Common Stock   30325   $0   32618   D    
Stock Option   $102.26   2/20/2018     J         25540   (3)   4/1/2016   (5) 4/1/2022   Common Stock   25540   $0   34382   D    
Stock Option   $104.82   2/20/2018     J         22716   (3)   4/1/2017   (6) 4/1/2023   Common Stock   22716   $0   48980   D    
Stock Option   $78.05   2/20/2018     J         10869   (3)   4/3/2018   (7) 4/3/2024   Common Stock   10869   $0   89310   D    

Explanation of Responses:
(1)  Represents restricted stock units (RSUs) that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, effective as of the end of the 90-day waiting period under a divorce decree, which waiting period ended on or about February 20, 2018. The RSUs held in trust for the ex-spouse are no longer beneficially owned by the reporting person.
(2)  Represents shares that have been transferred to the reporting person's ex-spouse pursuant to a divorce decree on various dates during the 90-day waiting period under the decree that ended on or about February 20, 2018. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person.
(3)  Represents stock options that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, effective as of the end of the 90-day waiting period under a divorce decree, which waiting period ended on or about February 20, 2018. The stock options held in trust for the ex-spouse are no longer beneficially owned by the reporting person.
(4)  Option became exercisable in four equal annual installments, commencing 4/1/2015.
(5)  Option became exercisable in four equal annual installments, commencing 4/1/2016.
(6)  Option became exercisable in four equal annual installments, commencing 4/1/2017.
(7)  Option becomes exercisable in four equal annual installments, commencing 4/3/2018.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Denton David M
ONE CVS DRIVE
WOONSOCKET, RI 02895-


EVP and CFO

Signatures
/c/ David M. Denton 2/21/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more CVS Health Charts.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more CVS Health Charts.